Akt/mTOR信号通路与口腔鳞状细胞癌的研究进展
-
摘要: 近年来随着对肿瘤研究的深入,人们逐渐认识到Akt/mTOR信号通路在肿瘤发生、发展中起重要作用。研究[1]表明,Akt/mTOR信号通路的异常在多种常见肿瘤如肝癌、肺癌、前列腺癌、子宫内膜癌以及口腔鳞状细胞癌等病变组织中发挥作用日益增强,将来可能会成为肿瘤治疗新靶点。本文就Akt/mTOR信号通路与口腔鳞状细胞癌的研究进展作一综述。
-
[1] Zhou X,Tan M,Stone Hawthorne V,et al. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers[J].Clin Cancer Res,2004,10(20):6779-6788. [2] Staal SP,Hartley JW,Rowe WP. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma[J]. Proc Natl Acad Sci U S A,1977,74(7):3065-3067. [3] Tomare DA,Testa JR. Perturbations of the AKT signaling pathway in human cancer[J]. Oncogene,2005,24(50):7455. [4] Stemke-Hale K,Gonzalez-Angulo AM,Lluch A,et al. An integrative genomic and proteomic analysis of PIK3CA,PTEN,and AKTmutations in breast cancer[J]. Cancer Res,2008,68(15):6084-6091. [5] Manning BD,Cantley LC. AKT/PKB signaling: navigating downstream[J]. Cell,2007,129(7):1261-1274. [6] Sheng S,Qiao M,Pardee AB. Metastasis and AKT activation[J].Cell Physiol,2009,218(3):451-454. [7] Zhou H,Huang S. The complexes of mammalian target of rapamycin[J]. Curr Protein Pept Sci,2010,11(6):409-424. [8] Sturgill TW,Hall MN. Activating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha[J]. ACS Chem Biol,2009,4(12):999-1015. [9] Potter CJ,Pedraza LG,Xu T. AKT regulates growth by directly phosphorylating TSC2[J]. Nat Cell Biol,2002,4(9):658-665. [10] Gwinn DM,Shackelford DB,Egan DF,et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint[J]. Mol Cell,2008,30(2):214-226. [11] Guertin DA,Sabatini DM. Defining the role of mTOR in cancer[J]. Cancer Cell,2007,12(1):9-22. [12] Peterson TR,Laplante M,Thoreen CC,et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myelomacells and required for their survival[J]. Cell,2009,137 (5):873-886. [13] Adjei AA,Hidalgo M. Intracellular signal transduction pathway proteins as targets for cancer therapy[J]. Clin Oncol,2005,23(23):5386-5403. [14] 陈英杰,刘健,陶雅君,等. PTEN、P13K 和 mTOR 在鼻咽癌中的表达及意义[J]. 现代肿瘤医学,2009,17(1):41-43. [15] 陈鸥,李野,赵明金,等. PTEN 基因真核荧光表达载体的构建及其在喉癌细胞株中的表达[J]. 吉林大学学报:医学版,2009,5(35):817-820. [16] Kinross KM,Montgomery KG,Kleinschmidt M,et al. An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice[J]. J Clin Invest,2012,122(2):553-557. [17] Inoki K,Corradetti MN,Guan KL. Dysregulation of the TSC-mTOR pathway in human disease[J]. Nat Genet,2005,37(1):19-24. [18] Ma L,Chen Z,Erdjumant-Bromage H,et al. Phosphorylation and funetiohal inactivation of TSC2 by Erk implications for tuberoug solerosis and cancer pathogenesis[J]. Cell,2005,121(2):179-193. [19] Keller JA,Acosta-Jaquez HA,Foster KG,et al. Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth[J]. Mol Cell Biol,2009,29(15):4308-4324. [20] Yang Q,Guan KL. Expanding mTOR signaling[J]. Cell Res,2007,17(8):666-681. [21] Pontes HA,de Aquino Xavier FC,da Silva TS,et al.Metallothionein and p-Akt proteins in oral dysplasia and in oralsquamous cell carcinoma:an immunohistochemical study[J]. J Oral Pathol Med,2009,38(8):644-650. [22] 刘发昱,李鹏,赵震锦,等. 人头颈鳞癌 CCR7 和 mTOR 表达关系研究[J]. 中国实用口腔科杂志,2011,4(7):407-409. [23] Chakraborty S,Mohiyuddin SM,Gopinath KS,et al. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma[J].BMC Cancer,2008,8:163. [24] Silva BS,Yamamoto FP,Pontes FS,et al. TWIST and p-Akt immunoexpression in normal oral epithelium,oral dysplasia and in oral squamous cell carcinoma[J]. Med Oral Patol Oral Cir Bucal,2012,17(1):e29- e34. [25] Pontes HA,de Aquino Xavier FC,da Silva TS. Metallothionein and p-Akt proteins in oral dysplasia and in oral squamous cell carcinoma:an immunohistochemical study[J]. Oral Pathol Med,2009,38(8):644-650. [26] Naruse T,Kawasaki G,Yanamoto S,et al. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas:correlation with the mTOR-HIF-1 pathway[J]. Anticancer Res,2011,31(12):4429-4437. [27] 刘奕,杨鸣良,张扬,等. 哺乳动物的雷帕霉素靶蛋白及其底物在口腔鳞状细胞癌中的表达[J]. 华西口腔医学杂志,2004,22(4):331-333. [28] Uesugi A,Kozaki K,Tsuruta T,et al. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor andinhibits AKT phosphorylation in oral cancer[J]. Cancer Res,2011,71(17):5765-5778. [29] Kapoor V,Zaharieva MM,Das SN,et al. Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt-mTOR signaling pathway in oral squamous cell carcinoma[J]. Cancer Lett,2012,19(1):39-48.
点击查看大图
计量
- 文章访问数: 3474
- HTML全文浏览量: 461
- PDF下载量: 88
- 被引次数: 0